Histone Demethylases
Histone Demethylases(组蛋白去甲基化酶)
Histone demethylases are a diverse group of enzymes catalyzing a process to reverse histone methylation, in which methyl (CH3-) groups are removed from instead of being transferred to histone. So far, two evolutionarily conserved histone demethylase families have been identified, including LSD demethylases and JMJC demethylases. LSD1 and LSD2 are two well-established members of LSD demethylase family, which catalyze demethylation through a flavin adenine dinucleotide (FAD)-dependent amine oxidation reaction. LSD1 has been found to demethylate H3K4mel, H3K4me2, H3K9me1, H3K9me2 and a few non-histone targets; while LSD2 has been found to demethylate only H3K4me1 and H3K4me2. Members of JMJC demethylase family is characterized by containing the catalytic JMJC domain, which demethylate substrates, including H3K4, H3K9, H3K27, H3K36 and H4K20, through a Fe(II)- and α-ketogutarate-dependent dioxygenase reaction.
Histone Demethylases 相关产品(103)
- GC15497GSK J4 HClCAS: 1797983-09-5纯度: >98.00%
GSK-J4 HCl 是一种小分子抑制剂,具有高效的细胞渗透性和药理学选择性抑制剂,可通过抑制 KDM6B 来保持 H3K27 甲基化。
- GC118732,4-Pyridinedicarboxylic AcidCAS: 499-80-9纯度: >99.00%
An inhibitor of 2-oxoglutarate-dependent enzymes
- GC12997GSK J4 free baseCAS: 1373423-53-0纯度: >99.50% / >98.00%
GSK J4 free base 是 H3K27me3/me2-去甲基化酶 JMJD3/KDM6B 和 UTX/KDM6A 的有效双重抑制剂,IC50 分别为 8.6 和 6.6 μM。 GSK J4 游离碱抑制 LPS 诱导的 TNF-α;在人原代巨噬细胞中产生,IC50 为 9 μM. GSK J4 是 GSK-J1 的细胞渗透性前药。 GSK J4 free base 诱导内质网应激相关的细胞凋亡。
- GC13534Lysine-specific Demethylase Inhibitor (1C)CAS: 927019-63-4
lysine-specific demethylase Inhibitor
- GC13919Tranylcypromine hydrochlorideCAS: 1986-47-6
An irreversible, mechanism-based inhibitor of LSD1
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC12961 | Apicidin | 183506-66-3 | >98.00% / >90.00% | |
A cell-permeable HDAC inhibitor | ||||
| GC15497 | GSK J4 HCl | 1797983-09-5 | >98.00% | |
GSK-J4 HCl 是一种小分子抑制剂,具有高效的细胞渗透性和药理学选择性抑制剂,可通过抑制 KDM6B 来保持 H3K27 甲基化。 | ||||
| GC18159 | BAY-598 | 1906919-67-2 | >99.50% | |
BAY-598是一种氨基吡唑啉基的选择性小分子抑制剂,靶点为含有SET和MYND结构域的蛋白2(SMYD2),半抑制浓度(IC 50 )为27nM。 | ||||
| GC10148 | RN 1 dihydrochloride | 1781835-13-9 | >98.00% | |
An irreversible LSD1 inhibitor | ||||
| GC10319 | TC-E 5002 | 1453071-47-0 | >98.00% | |
A KDM2/7 inhibitor | ||||
| GC10774 | CPI-455 | 1628208-23-0 | >98.50% / >98.00% | |
CPI-455是一种KDM5抑制剂,KDM5(Kissinger Demethylase 5)是一种赖氨酸特异性脱甲基酶,在染色质修饰中起着至关重要的作用,并参与各种生物学过程,包括肿瘤发展和免疫反应。 | ||||
| GC11578 | GSK2879552 | 1401966-69-5 | >99.50% | |
An LSD1 inhibitor | ||||
| GC11792 | OG-L002 HCl | 1357298-75-9 | - | |
An LSD1 inhibitor | ||||
| GC11873 | 2,4-Pyridinedicarboxylic Acid | 499-80-9 | >99.00% | |
An inhibitor of 2-oxoglutarate-dependent enzymes | ||||
| GC12288 | GSK-J1 sodium salt | 1797832-71-3 | - | |
A dual inhibitor of JMJD3 and UTX | ||||
| GC12458 | N-Oxalylglycine | 5262-39-5 | - | |
An inhibitor of JMJD2 histone demethylases | ||||
| GC12557 | ML324 | 1222800-79-4 | >98.50% | |
A cell-permeable inhibitor of JMJD2 demethylases | ||||
| GC12997 | GSK J4 free base | 1373423-53-0 | >99.50% / >98.00% | |
GSK J4 free base 是 H3K27me3/me2-去甲基化酶 JMJD3/KDM6B 和 UTX/KDM6A 的有效双重抑制剂,IC50 分别为 8.6 和 6.6 μM。 GSK J4 游离碱抑制 LPS 诱导的 TNF-α;在人原代巨噬细胞中产生,IC50 为 9 μM. GSK J4 是 GSK-J1 的细胞渗透性前药。 GSK J4 free base 诱导内质网应激相关的细胞凋亡。 | ||||
| GC13086 | GSK J2 | 1394854-52-4 | >99.50% | |
A negative control compound for GSK-J1 | ||||
| GC13534 | Lysine-specific Demethylase Inhibitor (1C) | 927019-63-4 | - | |
lysine-specific demethylase Inhibitor | ||||
| GC13919 | Tranylcypromine hydrochloride | 1986-47-6 | - | |
An irreversible, mechanism-based inhibitor of LSD1 | ||||
| GC14066 | Procaine | 59-46-1 | >99.00% | |
An Analytical Reference Standard | ||||
| GC14631 | SP2509 | 1423715-09-6 | >99.50% | |
A reversible inhibitor of LSD1 | ||||
| GC15301 | PBIT | 2514-30-9 | >98.00% / >99.50% | |
An inhibitor of JARID1 family demethylases | ||||
| GC15368 | GSK-LSD1 2HCl | 1431368-48-7 | - | |
不可逆的、选择性的 LSD1 抑制剂 | ||||
| GC15603 | JIB-04 | 199596-05-9 | >98.00% | |
JIB-04是一种泛选择性Jumonji组蛋白去甲基化酶抑制剂,对JARID1A、JMJD2E、JMJD3、JMJD2A、JMJD2B、JMJD2C和JMJD2D的IC 50 值分别为230nM、340nM、855nM、445nM、435nM、1100nM和290nM。 | ||||
| GC15830 | Daminozide | 1596-84-5 | >98.00% | |
Selective inhibitor of KDM2/7 histone demethylases | ||||
| GC16114 | Bizine | 1591932-50-1 | >95.00% | |
An LSD1 inhibitor | ||||
| GC17118 | GSK J5 | 1394854-51-3 | >95.00% | |
A negative control compound for GSK-J4 | ||||
